Characterisation and clinical features of Enterobacter cloacae bloodstream infections occurring at a tertiary care university hospital in Switzerland: Is cefepime adequate therapy?

International Journal of Antimicrobial Agents

Volumn 41, Issue 3, 2013, Pages 236-249

  Hilty, Markus ^a,b   Sendi, Parham ^a,b   Seiffert, Salome N ^a   Droz, Sara ^a   Perreten, Vincent ^a   Hujer, Andrea M ^c   Bonomo, Robert A ^c   Mühlemann, Kathrin ^a,b   Endimiani, Andrea ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

AmpC; AmpD; Bacteraemia; Cefepime; Enterobacter; Outcome

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN PLUS CLAVULANIC ACID; BETA LACTAMASE; BETA LACTAMASE AMPC; BETA LACTAMASE AMPD; CARBAPENEM; CEFAZOLIN; CEFEPIME; CEFTRIAXONE; CEPHALOSPORIN; CIPROFLOXACIN; COTRIMOXAZOLE; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; IMIPENEM; MEROPENEM; METRONIDAZOLE; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; BLOODSTREAM INFECTION; CLINICAL FEATURE; CLONAL VARIATION; COMORBIDITY; CONTROLLED STUDY; DISEASE SEVERITY; DRUG RESPONSE; ECL GENE; ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE INFECTION; ESCHERICHIA COLI; FEMALE; GENE DELETION; GENE MUTATION; HUMAN; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MICROARRAY ANALYSIS; MINIMUM INHIBITORY CONCENTRATION; MORTALITY; NUCLEOTIDE SEQUENCE; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; RISK FACTOR; SEPSIS; SEPTIC SHOCK; SWITZERLAND; TERTIARY HEALTH CARE; TREATMENT OUTCOME; UNIVERSITY HOSPITAL;

ADULT; AGED; ANTI-BACTERIAL AGENTS; BACTEREMIA; BETA-LACTAMASES; CEPHALOSPORINS; DRUG THERAPY, COMBINATION; ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE INFECTIONS; FEMALE; GENOTYPE; HOSPITALS, UNIVERSITY; HUMANS; INFECTION; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MOLECULAR TYPING; SURVIVAL ANALYSIS; SWITZERLAND; TERTIARY CARE CENTERS; TREATMENT OUTCOME;

EID: 84872955101     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2012.10.022     Document Type: Article

References (30)

1. R. Leclercq, R. Canton, D.F. Brown, C.G. Giske, P. Heisig, and A.P. Macgowan EUCAST expert rules in antimicrobial susceptibility testing Clin Microbiol Infect 2011 10.1111/j.1469-0691.2011.03703.x [Epub ahead of print]
2. W.E. Sanders Jr., and C.C. Sanders Enterobacter spp.: pathogens poised to flourish at the turn of the century Clin Microbiol Rev 10 1997 220 241 (Pubitemid 27196669)
3. P.N. Harris, and J.K. Ferguson Antibiotic therapy for inducible AmpC β-lactamase-producing Gram-negative bacilli: what are the alternatives to carbapenems, quinolones and aminoglycosides? Int J Antimicrob Agents 40 2012 297 305
4. K. Kaneko, R. Okamoto, R. Nakano, S. Kawakami, and M. Inoue Gene mutations responsible for overexpression of AmpC β-lactamase in some clinical isolates of Enterobacter cloacae J Clin Microbiol 43 2005 2955 2958 (Pubitemid 40827985)
5. D.M. Livermore, D.F. Brown, J.P. Quinn, Y. Carmeli, D.L. Paterson, and V.L. Yu Should third-generation cephalosporins be avoided against AmpC-inducible Enterobacteriaceae? Clin Microbiol Infect 10 2004 84 85 (Pubitemid 38128598)
6. A. Endimiani, F. Perez, and R.A. Bonomo Cefepime: a reappraisal in an era of increasing antimicrobial resistance Expert Rev Anti Infect Ther 6 2008 805 824
7. T.R. Walsh Emerging carbapenemases: a global perspective Int J Antimicrob Agents 36 Suppl. 3 2010 S8 S14
8. C.C. Lee, N.Y. Lee, J.J. Yan, H.C. Lee, P.L. Chen, and C.M. Chang Bacteremia due to extended-spectrum-β-lactamase-producing Enterobacter cloacae: role of carbapenem therapy Antimicrob Agents Chemother 54 2010 3551 3556
9. J.M. Bell, J.D. Turnidge, and R.N. Jones Prevalence of extended-spectrum β-lactamase-producing Enterobacter cloacae in the Asia-Pacific region: results from the SENTRY Antimicrobial Surveillance Program, 1998 to 2001 Antimicrob Agents Chemother 47 2003 3989 3993 (Pubitemid 37485024)
10. A.R. Marra, L.F. Camargo, A.C. Pignatari, T. Sukiennik, P.R. Behar, and E.A. Medeiros Nosocomial bloodstream infections in Brazilian hospitals: analysis of 2,563 cases from a prospective nationwide surveillance study J Clin Microbiol 49 2011 1866 1871
11. Z.A. Qureshi, D.L. Paterson, D.L. Pakstis, J.M. Adams-Haduch, G. Sandkovsky, and E. Sordillo Risk factors and outcome of extended-spectrum β-lactamase-producing Enterobacter cloacae bloodstream infections Int J Antimicrob Agents 37 2011 26 32
12. J.A. Lee, C.I. Kang, M.K. Joung, S.Y. Moon, D.R. Chung, and K.S. Ko Efficacy of cefepime therapy for Enterobacter bacteraemia, with special emphasis on febrile neutropenic patients Scand J Infect Dis 42 2010 557 559
13. C.I. Kang, S.H. Kim, W.B. Park, K.D. Lee, H.B. Kim, and M.D. Oh Bloodstream infections caused by Enterobacter species: predictors of 30-day mortality rate and impact of broad-spectrum cephalosporin resistance on outcome Clin Infect Dis 39 2004 812 818
14. M. Marcos, A. Inurrieta, A. Soriano, J.A. Martinez, M. Almela, and F. Marco Effect of antimicrobial therapy on mortality in 377 episodes of Enterobacter spp. bacteraemia J Antimicrob Chemother 62 2008 397 403 (Pubitemid 351984788)
15. Y. Ye, J.B. Li, D.Q. Ye, and Z.J. Jiang Enterobacter bacteremia: clinical features, risk factors for multiresistance and mortality in a Chinese university hospital Infection 34 2006 252 257 (Pubitemid 44563982)
16. European Committee on Antimicrobial Susceptibility Testing. Clinical breakpoints v.20. Basel, Switzerland: EUCAST; 2012. http://www.eucast.org [accessed 23.11.12].
17. W.M. Dunne Jr., and D.J. Hardin Use of several inducer and substrate antibiotic combinations in a disk approximation assay format to screen for AmpC induction in patient isolates of Pseudomonas aeruginosa, Enterobacter spp., Citrobacter spp., and Serratia spp. J Clin Microbiol 43 2005 5945 5949 (Pubitemid 43100642)
18. P. Bogaerts, A.M. Hujer, T. Naas, R.R. de Castro, A. Endimiani, and P. Nordmann Multicenter evaluation of a new DNA microarray for rapid detection of clinically relevant bla genes from β-lactam-resistant Gram-negative bacteria Antimicrob Agents Chemother 55 2011 4457 4460
19. A.M. Hujer, M.G. Page, M.S. Helfand, B. Yeiser, and R.A. Bonomo Development of a sensitive and specific enzyme-linked immunosorbent assay for detecting and quantifying CMY-2 and SHV β-lactamases J Clin Microbiol 40 2002 1947 1957 (Pubitemid 34596367)
20. M. Hilty, B.Y. Betsch, K. Bögli-Stuber, N. Heiniger, M. Stadler, and M. Kuffer Transmission dynamics of extended-spectrum β-lactamase-producing Enterobacteriaceae in the tertiary care hospital and the household setting Clin Infect Dis 55 2012 967 975
21. M.E. Charlson, P. Pompei, K.L. Ales, and C.R. MacKenzie A new method of classifying prognostic comorbidity in longitudinal studies: development and validation J Chronic Dis 40 1987 373 383 (Pubitemid 17055592)
22. W.R. McCabe, and G.G. Jackson Etiology and ecology Arch Intern Med 110 1962 847 862
23. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992;20:864-74.
24. A.S. Levey, J.P. Bosch, J.B. Lewis, T. Greene, N. Rogers, and D. Roth A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group Ann Intern Med 130 1999 461 470 (Pubitemid 29135798)
25. A. Endimiani, F. Luzzaro, M. Perilli, G. Lombardi, A. Coli, and A. Tamborini Bacteremia due to Klebsiella pneumoniae isolates producing the TEM-52 extended-spectrum β-lactamase: treatment outcome of patients receiving imipenem or ciprofloxacin Clin Infect Dis 38 2004 243 251 (Pubitemid 38113033)
26. C. Pluss-Suard, A. Pannatier, A. Kronenberg, K. Muhlemann, and G. Zanetti Hospital antibiotic consumption in Switzerland: comparison of a multicultural country with Europe J Hosp Infect 79 2011 166 171
27. A.L. Vlek, M.J. Bonten, and C.H. Boel Direct matrix-assisted laser desorption ionization time-of-flight mass spectrometry improves appropriateness of antibiotic treatment of bacteremia PLoS ONE 7 2012 e32589
28. J.M. Rodríguez-Martínez, P. Fernández-Echauri, F. Fernández-Cuenca, P. Diaz de Alba, A. Briales, and A. Pascual Genetic characterization of an extended-spectrum AmpC cephalosporinase with hydrolysing activity against fourth-generation cephalosporins in a clinical isolate of Enterobacter aerogenes selected in vivo J Antimicrob Chemother 67 2012 64 68
29. S.B. Vakulenko, D. Golemi, B. Geryk, M. Suvorov, J.R. Knox, and S. Mobashery Mutational replacement of Leu-293 in the class C Enterobacter cloacae P99 β-lactamase confers increased MIC of cefepime Antimicrob Agents Chemother 46 2002 1966 1970 (Pubitemid 34535222)
30. Clinical and Laboratory Standard Institute. Performance standards for antimicrobial susceptibility testing; 22nd informational supplement. Document M100-S22. Wayne, PA: CLSI; 2012.